AbbVie | ABBV - 이자 수익





이자 수익 변화 날짜
AbbVie USD 59M 13M 2025-12
Abbott USD 78M 1000K 2025-12
ALKERMES USD 8.54M 3.59M 2026-03
AstraZeneca USD 73M 62M 2026-03
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eisai JPY 3.11B 783M 2024-03
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
J&J USD 2.14 237M 2026-03
Medtronic USD 114M 23M 2025-01
Merck USD 69M 27M 2025-12
Pacira USD 2.3M 6.24M 2025-12
Pfizer USD 115M 51M 2026-03
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
United Therapeutics USD 43.2M 3.2M 2025-12
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03
Zoetis USD 25M 1000K 2025-12